Please Wait
Applying Filters...
menu
    • menu
    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Together we can improve the quality of life

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Glecirasib

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Jacobio Hits 71% ORR, Paves Way for First SHP-2 NSCLC Therapy
    Jacobio Hits 71% ORR, Paves Way for First SHP-2 NSCLC Therapy

    04 Dec 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/clinical-trials/jacobio-combo-delivers-71-orr-sets-stage-for-first-shp-2based-nsclc-therapy-18447

    INDPHARMAPOST
    04 Dec 2025
    Share Share
    Registrational Clinical Data of Glecirasib was Published
    Registrational Clinical Data of Glecirasib was Published

    06 Jan 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/the-registrational-clinical-data-of-glecirasib-was-published-in-nature-medicine-302342827.html

    PR NEWSWIRE
    06 Jan 2025
    Share Share
    Jacobio Out-Licenses KRAS And SHP2 Inhibitors To Allist In China
    Jacobio Out-Licenses KRAS And SHP2 Inhibitors To Allist In China

    31 Aug 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/jacobio-out-licensed-kras-g12c-inhibitor-glecirasib-and-shp2-inhibitor-jab-3312-to-allist-in-china-302234967.html

    PR NEWSWIRE
    31 Aug 2024
    Share Share
    Jacobio plans bid for China’s KRAS market with safety edge
    Jacobio plans bid for China’s KRAS market with safety edge

    02 May 2024

    // Phil Taylor PHARMAPHORUM

    https://pharmaphorum.com/news/jacobio-plans-bid-chinas-kras-market-safety-edge

    Phil Taylor PHARMAPHORUM
    02 May 2024
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.